Vazyme Biotech is Biotechnology in China that focus on high-throughput sequencing business. Founded in 2012. They cover business area such as developer, biotechnology, enzyme, antibody product, clinical diagnosis, molecular diagnostic, high-throughput sequencing and life science research, RNA, customer, reagent manufacturer, high resistance.
2012
( 12 years old in 2024 )
High-throughput Sequencing
-
Building C2, Hongfeng Science and Technology Park
Kechuang Road, Nanjing Economic and Technological Development Zone
Nanjing, Jiangsu
China
Private
developerbiotechnologyenzymeantibody productclinical diagnosismolecular diagnostichigh-throughput sequencing and life science researchRNAcustomerreagent manufacturerhigh resistance
* We use standard office opening hours in near Vazyme Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vazyme Biotech is Biotechnology business from China that founded in 2012 (12 years old in 2024), Vazyme Biotech business is focusing on High-throughput Sequencing.
Vazyme Biotech headquarter office and corporate office address is located in Building C2, Hongfeng Science and Technology Park Kechuang Road, Nanjing Economic and Technological Development Zone Nanjing, Jiangsu China.
Vazyme Biotech was founded in China.
In 2024, Vazyme Biotech is currently focus on high-throughput sequencing sector.
Above is snippet of Google Trends for "high-throughput sequencing" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vazyme Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
